Hepatitis From Injection Drug Use

Hepatitis And Injection Drug Use

Injection drug use is a significant risk factor for contracting viral hepatitis, especially hepatitis B and hepatitis C. The most common source of infection is through the sharing of needles, syringes, and other injection paraphernalia, which can carry small amounts of blood from one person to another. Tiny traces of infected blood can transmit the virus.

Injecting drugs bypasses the body’s natural defenses, allowing viruses to enter the bloodstream directly. Understanding this connection is basic for implementing prevention efforts and public health initiatives aimed at reducing the spread of these serious liver infections.

Types Of Viral Hepatitis

Viral hepatitis is an inflammation of the liver caused by a virus. A few different viruses can cause hepatitis, with the most common types in the U.S. being hepatitis A, hepatitis B, and hepatitis C.

• Hepatitis A: Hepatitis A is commonly spread through the consumption of contaminated water, the ingestion of contaminated food, or close contact with an infected person. While hepatitis A is not directly linked to injection drug use through blood-to-blood contact, poor sanitation and hygiene practices associated with drug use can increase the risk of transmission. Hepatitis A is usually a short-term illness and does not become chronic.
• Hepatitis B: Hepatitis B is transmitted and contracted through contact with infected blood, semen, or other body fluids. Sharing needles, syringes, or other injection supplies is a common way the hepatitis B virus is transmitted. Hepatitis B can be either acute or chronic. Chronic hepatitis B can lead to serious health problems like cirrhosis (scarring of the liver) and liver cancer.
• Hepatitis C: Hepatitis C is transmitted through contact with infected blood. Similar to hepatitis B, sharing needles and syringes is the most common way hepatitis C spreads. A significant percentage of people who inject drugs have been exposed to hepatitis C. Hepatitis C is often a chronic infection and can cause severe liver damage over time, including cirrhosis and liver cancer.

Hepatitis D and E are less common in the U.S. Hepatitis D only occurs in people who are already infected with hepatitis B and is spread through contact with infected blood. Hepatitis E is spread through contaminated water and is rare in developed countries.

Explore These Featured Centers

Symptoms Of Hepatitis

The symptoms of viral hepatitis can vary depending on the type of hepatitis and whether the infection is acute or chronic. Many people in the early stages of chronic hepatitis B or C may have no symptoms at all. When symptoms do occur, they can range from mild to severe.

Symptoms of acute hepatitis can include:

• Fatigue
• Nausea and vomiting
• Abdominal pain, particularly in the upper right side
• Loss of appetite
• Fever
• Dark urine
• Pale stools
• Jaundice (yellowing of the skin and eyes)
• Joint pain

In chronic hepatitis B or C, symptoms may not appear for many years, until the virus has caused significant liver damage. Symptoms of chronic hepatitis can include:

• Ongoing fatigue
• Persistent nausea or loss of appetite
• Abdominal swelling
• Swelling in the legs and ankles
• Weight loss
• Easy bruising or bleeding
• Jaundice
• Confusion, drowsiness, and slurred speech (hepatic encephalopathy)

Experiencing these symptoms does not automatically mean a person has hepatitis, as other conditions can cause them. That said, if someone has engaged in activities that put them at risk, such as injection drug use, and is experiencing these symptoms, they should seek medical attention for testing and diagnosis.

What Is The Relationship Between Drug Use And Viral Hepatitis?

The primary cause of viral hepatitis is the transmission of viruses through blood. This is particularly true of hepatitis B and hepatitis C. Transmission happens through the sharing of needles and other methods of using drugs. The risk of coming into contact with infected blood is high if people share needles, syringes, cotton, water, or other items while injecting. Even tiny amounts of blood can contain enough virus to cause infection.

People often share injection paraphernalia due to factors such as the cost and availability of sterile supplies. The fear of arrest is also present in many places, as carrying or accessing clean needles and syringes may be illegal, increasing the likelihood of sharing.

Drug use can indirectly increase the risk of hepatitis, as impaired judgment due to intoxication from any drug can lead to risky behaviors, including unprotected sexual activity. This is another route of transmission for hepatitis B and, to a lesser extent, hepatitis C. Additionally, some people who use non-injection drugs may still be at risk if they share items like straws for snorting drugs, which can cause nasal membranes to bleed and potentially transmit viruses.

The relapsing nature of addiction can also contribute to the spread of hepatitis. The need to obtain drugs may lead individuals to neglect their health, including not seeking testing and treatment for hepatitis or accessing harm reduction services. All of these can result in undiagnosed infections and continued transmission within the community.

Risk Of Hepatitis In IV Drug Users

The risk of acquiring hepatitis is high in people who inject drugs compared to the general population. This is due to the direct transmission of bloodborne viruses through the sharing of injection equipment. According to the Centers for Disease Control and Prevention (CDC), injection drug use is the most common risk factor for new hepatitis C infections in the United States. Data show that within the first two years of injecting, a substantial percentage of individuals contract hepatitis C.

The risk of contracting hepatitis is not limited to sharing needles and syringes, as the hepatitis C virus can survive outside the body for several weeks. This means that sharing any means of injection can also transmit the virus. The frequency of injection and the number of individuals with whom equipment is shared also influence the level of risk.

Even though hepatitis B is less prevalent than hepatitis C, it still poses a significant risk. Just as with hepatitis C, the sharing of injection paraphernalia results in a high rate of transmission for hepatitis B. Furthermore, individuals who have both hepatitis B and hepatitis C may experience more rapid progression of liver disease.

Hepatitis A can also be higher among people who inject drugs, even though the transmission route is different. Factors such as homelessness, unstable housing, and limited access to clean water and sanitation can sometimes be associated with drug use and increase the risk of hepatitis A transmission through the fecal-oral route.

The high rates of hepatitis among people who inject drugs point to the urgent need for targeted prevention strategies, including access to sterile injection equipment, vaccination, and comprehensive harm reduction programs.

Care That's Covered by Insurance

Explore rehabs that accept your insurance today! Start your recovery journey with peace of mind, knowing your care is covered.

Find Rehab by Insurance Provider

Addiction Center is not affiliated with any insurance.

Syringe Services Programs

Needle exchange programs or Syringe Services Programs (SSPs) are an essential part of harm reduction programs that reduce the transmission of HIV, hepatitis B, and hepatitis C.

These programs offer sterile needles, syringes, and other injection supplies in exchange for used ones. By providing access to clean supplies, these programs help prevent the sharing of contaminated materials. This reduces the risk of bloodborne infections.

SSPs offer more than just sterile syringes. They often provide a range of services, including:

• Education on safer injection practices
• Referrals to substance use treatment programs
• Testing and counseling for HIV, hepatitis, and other sexually transmitted infections
• Vaccination for hepatitis A and B
• Distribution of naloxone, a medication that can reverse an opioid overdose
• Referrals to medical care and social services

Research shows that these programs are effective in reducing the transmission of HIV and hepatitis C without increasing rates of drug use. Studies suggest that people who use these programs are more likely to enter drug treatment than those who do not. These types of programs are endorsed and encouraged by major public health organizations, including the CDC, the World Health Organization, and the American Medical Association, as an evidence-based approach for preventing infectious diseases and promoting public health.

Despite this support, programs face challenges, including funding limitations, legal restrictions in some areas, and community opposition. Expanding access is necessary to curb the spread of hepatitis and other bloodborne infections among people who inject drugs and improve their overall health and well-being.

Living With Viral Hepatitis

Living with viral hepatitis, particularly chronic hepatitis B or C, can be challenging, both physically and emotionally. Fatigue is a common problem that can impact daily life and the ability to work or participate in activities. Emotional distress, including the possible shame associated with the diagnosis, as well as anxiety and depression, creates the potential for serious health complications.

Managing viral hepatitis often involves regular medical care, including monitoring liver function and viral levels. For hepatitis B, treatment typically involves antiviral medications to suppress the virus and prevent further liver damage. For hepatitis C, effective antiviral medications are available that can cure the infection in most cases, but strict adherence to treatment regimens is crucial for successful outcomes.

People living with viral hepatitis should adopt healthy lifestyle habits to protect their liver. This includes avoiding alcohol, which can accelerate liver damage, and maintaining a healthy diet and weight. They should also be vaccinated against hepatitis A and B if they are not already immune.

Connecting with support groups, counseling services, or peer support networks can be vital for providing emotional support, practical advice, and a sense of community. Open communication with healthcare providers is necessary to address concerns, manage symptoms, and ensure access to appropriate care and treatment. It is important to remember that those with hepatitis can manage their condition, prevent further liver problems, and maintain a good quality of life with proper medical care and support.

Treatment For Injection Drug Users

Treating viral hepatitis in people who inject drugs requires addressing both the viral infection and the substance use. Effective treatment for hepatitis B and C is available and can significantly improve overall health and prevent the progression of liver disease. However, engaging and retaining people who inject drugs in hepatitis treatment can be challenging due to various factors, including unstable housing, lack of access to healthcare, stigma, and competing priorities, such as maintaining an income and taking care of others.

Substance use treatment is a critical component of comprehensive care for people with hepatitis who inject drugs. Treatment for substance use can help individuals reduce or stop their drug use, which in turn reduces the risk of reinfection with hepatitis and improves overall health. Treatment options for substance use disorders include:

• Medication-assisted treatment (MAT): MAT involves the use of medications, such as methadone, buprenorphine, or naltrexone, in combination with counseling and behavioral therapies. MAT is considered the gold standard for treating opioid use disorder and has proven to be effective in reducing drug use, preventing overdose, and improving retention in treatment. Unfortunately, MAT is still underutilized.
• Counseling and behavioral therapies: Various therapies, such as cognitive-behavioral therapy (CBT), recognition of the role of shame, contingency management, and motivational interviewing, can help individuals identify and change behaviors related to drug use, develop coping skills, and build motivation for recovery.
• Support groups: Peer support groups, such as Narcotics Anonymous (NA), can provide a supportive environment for individuals in recovery to share their experiences and receive encouragement from others who have faced similar challenges.

Medical care combined with substance use treatment services is essential to improve access to and completion of hepatitis treatment among people who inject drugs. This can involve having complementary services located in the same area, using navigators to help individuals access care, and providing outreach in the community. Addressing social factors, such as housing instability and a lack of insurance, is also essential to support treatment engagement and adherence.

Treating hepatitis in people who inject drugs improves individual health outcomes and also has significant public health benefits by reducing the number of infected individuals and preventing further transmission of the virus.

Seeking Help And Support

If you are someone who injects drugs and are concerned about your risk of hepatitis, or if you have been diagnosed with viral hepatitis, help and support are available. A healthcare provider can test for hepatitis, assess the health of your liver, and discuss treatment options. Seeking medical care is the first step.

Contacting harm reduction services, such as Syringe Services Programs, can provide you with sterile injection supplies and education on safer practices. They, in turn, can connect you with other health and social services.

If you are struggling with injection drug abuse that is putting you at a higher risk for contracting hepatitis, there are many options for substance use treatment, including inpatient and outpatient treatment. Explore our rehab directory or contact a treatment provider to learn more about your treatment options.

Remember, you do not have to face these challenges alone. Reaching out for help is a sign of strength, and there are people and resources available to support you in managing your health and well-being.